EORTC-24982-HNCG

Phase II study on Gemcitabine in Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Trial StatusAll trial activities ended
DatesDate of activation: 02-Apr-01
Closed on : 25-Apr-03
Data management at EORTCFull
Phase2
Randomized trial
Type-
Targeted Sample size29
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT numberNCT00017498
EudraCT